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Adenovirus vectors are known to induce certain genes and impact innate response networks, but a broad understanding of this process and its
mechanisms is currently lacking. For this reason, we chose to investigate and characterize Ad innate immunity using homogeneous, primary MEF
cells replete with all the elements of the pathogen-sensing Toll-Like Receptor (TLR) pathway. By using an array-based approach to maximally
define transcriptome changes induced upon Ad vector infection, we discovered that Ad infection induces a potent gene and transcription factor
network response. This response is characterized by significant changes in the expression of genes involved in focal adhesion, tight junction, and
RNA regulation, in addition to TLR pathway and other innate sensing genes. Further investigation using human A549 cells knocked down for
various TLR pathway adaptors, revealed significant impacts on the Ad initiation of NF-kB and interferon responses, thus confirming TLR
involvement in Ad-mediated immunity across diverse species.
© 2006 Elsevier Inc. All rights reserved.Keywords: Ad; Innate immune response; Microarray; Toll-like receptorIntroduction
Adenovirus (Ad) is a member of the Adenoviridae family of
nonenveloped DNA viruses. Its linear double-stranded DNA
genome is encapsulated within an icosahedral protein capsid, a
structure that is shared by many other viral lineages, from
Eukaryotic pathogens (HPV, reovirus, Ad), to Bacterial
pathogens (such as PRD1), as well as Archaea pathogens
(Benson et al., 2004, 1999). Adenoviridae virions infect a wide
variety of animals (frogs, fish, birds, mammals, etc.) and are
responsible for a repertoire of disparate pathologies ranging
from mild irritations to constitutive infections.
Perhaps due to its promiscuous evolutionary history, Ad
retains the ability to infect a wide range of non-dividing host
cells through multiple entry pathways. This ability to infect non-⁎ Corresponding author. 4194 Biomedical and Physical Sciences Bldg.,
Michigan State University, East Lansing, MI 48823, USA.
1 Current address: Department of Pharmaceutical Sciences, University of
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doi:10.1016/j.virol.2006.08.041dividing host cells, particularly in an in vivo setting, makes
genetically modified Ads attractive candidates for many gene
transfer applications. While the first generations of these vectors
were engineered with simple ablations of the Ad early genes,
dissection and manipulation of the Ad genome has progressed
to the point where fully ‘gutted’ Ad vectors (devoid of most of
the Ad genome) can be easily made. Despite these advances in
vectorology, it has become abundantly clear that Ad-mediated
gene transfer induces profound changes within target cells, due
to continued interactions with the intact viral capsid (Liu et al.,
2003; Zaiss et al., 2002; Jooss and Chirmule, 2003).
Ad target cell transduction is a complex multi-step process
that precipitates a rapid activation of the cellular innate immune
response. For example, infection of human embryonic kidney
cells with UV-inactivated Ad vectors (ablated viral gene
expression) was still able to induce the expression of several
chemokines, particularly RANTES, IP-10, and MIP-2, con-
firming that the Ad capsid itself initiates many of these
responses. Ad infection of non-immune specialized cell lines,
such as HeLa, A549 respiratory epithelial cells, and the TGP61
358 Z.C. Hartman et al. / Virology 358 (2007) 357–372mouse insulinoma cell line, shows similar chemokine activa-
tion patterns after Ad infection, with noted induction of IL-8 as
well (Liu and Muruve, 2003). Other strongly induced genes in
epithelial and endothelial cells include various leukocyte
adhesion molecules, for example ICAM-1 and VCAM-1,
suggesting Ad activation of a general inflammatory cascade in
non-innate cells. These responses occur rapidly after initial Ad
interactions with a cell, with p42/MAPK phosphorylation and
ERK signaling occurring within 10 min of initial Ad exposure
in A549 cells (Melotti et al., 2001). A similar reaction occurs in
REC cells (an epithelial line) with p38 and ERK activation
occurring 10 min post-transduction (Borgland et al., 2000).
These early signaling events seem directly linked to the
subsequent expression of chemokines, given that pharmaco-
logical inhibitors of p38 and ERK directly inhibited IP-10
expression (Tibbles et al., 2002). Activation and release of NF-
kB, and its downstream transcriptional activities also figure
prominently in Ad induction of cytokine/chemokines both in
vitro and in vivo (Melotti et al., 2001; Loser et al., 1998;
Tamanini et al., 2003; Bowen et al., 2002).
While certain immune genes and pathways are known to
be stimulated by Ad infection, the signaling cascade
architecture governing the Ad innate response remains
uncharacterized. Utilizing array-based transcriptome analysis
and a cell culture system maximally capable of innately
responding to infection, the current investigation underscores
this premise, establishing an annotation of the transcriptional
networks engaged by Ad vector infection. The identification
of a putative transcription factor network and confirmation of
induced transcription factors further this global picture,
providing new insight into Ad immune gene stimulation. In
particular, microarray analysis of Ad-induced genes revealed
Toll-Like Receptor (TLR) gene involvement. To ascertain the
TLR system's involvement in Ad-mediated immunity, specific
investigation of several different TLR-related adaptor genes
was conducted and revealed that Ad immune gene,
transcription factor, and cytokine activation are significantly
dependant upon TLR-mediated signaling in human A549
cells. As a result, this work not only delineates previously
unrecognized gene networks activated upon Ad infection, but
can thusly serve as a foundation for future studies
investigating the role of the many different elements of the
Ad-induced innate immune response.
Results
Infection of quiescent fibroblasts with an [E1−,E3−] Ad
serotype 5 expressing the bacterial B-galactosidase gene
(LacZ)
To critically investigate the global cellular response to an Ad
infection, primary mouse embryonic fibroblast cell isolates
(MEFs) were obtained from a uniform genetic background of
mice (C57Bl/6) that has been frequently used in different
adenoviral vector in vivo studies (Everett et al., 2004, 2003; Tao
et al., 2001; Varnavski et al., 2005). This approach was selected
to reduce variability, as well to avoid clonal drift and potentialepigenetic influences present in many immortalized cell lines
(Masters, 2000). While many murine cell types show different
restrictions on active adenoviral replication, C57Bl/6 MEFs
have been verified to be permissive for active adenoviral
genome replication (Younghusband et al., 1979) and also have
been demonstrated to be highly responsive to different
pathogens and thus represent an excellent model for studying
the host–pathogen interaction at a cellular level (Kurt-Jones et
al., 2004). This is likely due to the fact that MEFs (from the
C57Bl/6 strain) express high levels of TLRs 1–9 and are highly
responsive to all known TLR-ligand-induced activations both in
terms of mRNA expression and cytokine elaboration (Kurt-
Jones et al., 2004). In contrast, other often utilized cell lines
offer variable expression of several TLRs, cytokines, and/or are
composed of heterogenous populations, each of which may
limit the scope of detecting Ad induction of innate sensing
pathways (Kurt-Jones et al., 2004).
MEFs were brought to quiescence by serum starvation as our
experience and the experiences of others have demonstrated that
changes in growth rate and cell cycle control can obscure and
overwhelm changes in cellular gene expression due to viral
infection (Ray and Enquist, 2004).
Growth arrested MEFs were either mock-infected, or
infected at Multiplicity of Infection (MOI) of 300 LacZ
transducing units with a LacZ expressing [E1−,E3−] Ad
vector, and total RNA was subsequently extracted for analysis
at 16 h post-infection (pi) from all samples. At this MOI, more
than 90% of the fibroblasts were successfully infected, with
infectivity being confirmed by visualization of X-gal stained
fibroblasts (see Fig. 1). Prior to use, RNA integrity was
checked using an Agilent Lab-on-a-Chip 2100 Bioanalyzer to
ensure quality control for the RNA utilized in all subsequent
manipulations (see Methods). Expression data sets were
imported into Genespring software, normalized, and filtered
as described in Methods. The filtered data set consisted of
5313 gene probes.
To identify those gene transcripts that were differentially
(and significantly) expressed between mock or Ad-infected
MEFs, a one-way ANOVA analysis (p≤0.05) was performed
with an additional Benjamin and Hochberg False Discovery
Rate (FDR), used as a form of Multiple Testing Correction. This
identified ∼1109 gene probes that showed a significant
difference in expression level, between mock and Ad-infected
MEFs. The majority of these were upregulated, and while levels
of upregulation varied greatly, on average, induction levels
ranged from 2 to 3-fold (see Table 1). While non-statistical
judgments based on average fold differences in expression level
yielded larger numbers of dysregulated genes, stringent
statistical tests still revealed that ∼22% of all ascertainable
genes had their expression levels significantly affected by Ad
infection. A significant proportion of these genes (∼33%)
showed upregulation of 3-fold or more, suggesting significant
ramifications for cellular physiology. The magnitude of this
inductive phenomenon is most clearly demonstrated upon gross
inspection of a hierarchically clustered heat map of the results
(Fig. 2). This figure was generated by inclusion of all MEF
genes identified whose expression is significantly different in
Fig. 1. Productive infection of murine embryonic fibroblasts (MEFs). MEFs
were cultured as described in Methods, then infected (A) with a LacZ Ad
(MOI=300), (B) a UV-irradiated Ad (MOI=300), (C) mock-infected or (D)
CHX (100 μg/mL) treatment (beginning 3 h) prior to infection with a LacZ Ad
(MOI=300). At 16 hpi, cells were X-gal stained to ascertain the percentage of
cells successfully infected, as well to confirm the efficiency of UV-Ad
irradiation and CHX protein synthesis suppression.
359Z.C. Hartman et al. / Virology 358 (2007) 357–372Ad-infected MEFs relative to mock-infected MEFs. In this
graphical representation of the microarray results, each column
represents a different sample and each row within a sample
represents a single gene, the color of which demonstrates the
relative level of expression of that gene (red highest, yellow
intermediate, blue lowest). Those genes with similar levels of
expression are clustered with other genes with similar levels of
expression.
Identity of pathways and gene group functions affected by Ad
infection
The significantly Ad-induced (or repressed) MEF genes (as
determined by one-way ANOVA analysis (p≤0.05) using FDR)Table 1
Ad-mediated dysregulation of cellular transcription
Group numbers
and percentages
Upregulated 2-fold increas
Significantly different probes a, b 1109 total probes 864 probes 638 probes
Percentage of total probes b ∼21% of total
probes in array
∼16% of total ∼12.0% of to
Significantly different probes a, b 335 probes 298 probes 271 probes
Percentage of total probes b ∼6.3% of total ∼5.6% of total 5.1% of total
All probes b 5313 total probes 3143 probes 878 probes
Percentage of total probes b 100% ∼59% of total ∼16.5% of to
Global assessment of Ad-mediated transcriptome dysregulation 16 hpi after infection o
B array set.
a Significantly different probes were determined by a one-way ANOVA analysis u
of multiple testing correction.
b All probe sets were quality filtered to ensure probe signal in the majority of arwere next investigated using Expression Analysis Systematic
Explorer (EASE) and Gene Ontology Tree Machine (GOTM) to
identify which known pathways and/or gene groups are affected
by Ad infection. These programs used rigorous statistical
methods to determine significant involvement of various gene
groups (based upon gene Biological Function, Molecular
Function, and Cellular Location) or known gene pathways
identified as induced or repressed after Ad infection of cells
(Supplementary Tables 1–2) (Zhang et al., 2004; Hosack et al.,
2003). To further understand what gene pathways or groups
were most dramatically affected subsequent to Ad infection,
statistically significant genes that were more than 3-fold-induced
or repressed were also independently investigated (Supplemen-
tary Tables 3–4).
Gene function analysis revealed that Ad infection induced a
significant transcriptional upregulation of RNA and nucleotide
binding, cell cycle, proliferation, immune response, GTP
Binding, ATPase Activity, Protein Folding, DNA Replication,
RNA Processing, Extracellular Structural Constituents, Lipid
Binding, and Heat Shock groups of genes (see Fig. 3 and
Supplementary Table 1). When highly (more than 3-fold) Ad-
induced genes were independently examined, the most over-
represented GO categories included Antigen Processing, Cell
Cycle, Hydrolase Activity, Heat Shock Proteins, and Cytoki-
nesis genes, in addition to many immune response genes (see
Fig. 3 and Supplementary Table 3). The inclusion of many
defense/immune-related genes as being highly upregulated led
us to more closely investigate the induction of these genes (see
below), although the inclusion of significant numbers of Cell
Cycle, RNA processing, and Proliferation genes was unex-
pected. Many of these immune and cell cycle genes also had
metabolism-related functions and thus certain metabolism-
related genes emerged as an important highly upregulated gene
group. Additionally, Antigen Processing/Presentation and
Heme Biosynthesis activity genes emerged as significant only
in the highly induced genes, although the majority of functional
gene groups could be identified equally in both groups.
Ad infection simultaneously suppressed expression of
Catalytic Activity, various metabolic pathways (lipid and
aromatic compounds), and small Monomeric GTPase Activity
gene groups (see Fig. 3 and Supplementary Tables 2 and 4).e 3-fold increase Downregulated 2-fold decrease 3-fold decrease
283 probes 245 probes 123 probes 41 probes
tal ∼5.3% of total ∼4.6% of total ∼2.3% of total ∼0.8% of total
163 probes 37 probes 28 probes 9 probes
∼3.1% of total ∼0.007% of total ∼0.005% of total ∼0.002% of total
312 probes 2170 probes 446 probes 212 probes
tal ∼5.9% of total ∼41% of total ∼8.4% of total ∼4.0% of total
f quiescent MEFs with a [E1−,E3−] AdLacZ vector using a Murine Affy 11 k A/
sing a p<0.05 and a Benjamin and Hochberg False Discovery Rate as the form
ray samples and were eliminated from analysis if found to be otherwise.
Fig. 2. Heat map of genes significantly dysregulated after Ad infection of MEFs.
Those genes whose expression was significantly dysregulated after Ad infection
were identified using a one-way ANOVA, p=0.05, with a BH FDR, and the
relative expression of each of these genes (in either mock-infected MEFs or Ad-
infected MEFs) is depicted in this graphical heat map. Each vertical column
represents an individual sample (n), where n=5 for mock-infected fibroblasts
and n=6 for infected fibroblasts. Each row represents a single gene. The more
transcriptionally active a gene is, the greater the intensity is the shade of red,
while less transcriptionally active genes are depicted by greater intensity of
shades of blue. In this heat map, the 2 groups of samples were hierarchically
clustered (by relative level of gene expression) using a Pearson's correlation.
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catabolism, making this the predominant function of those
genes whose expression is downregulated after Ad infection.
When the most highly downregulated genes (>3-fold) were
examined, the impact of catalytic activity became even more
apparent (p<0.0005; see Supplementary Table 4).
When specific, known pathways were investigated, Ad-
infected cells revealed statistically significant upregulation of
the MAP Kinase, Focal Adhesion, Tight Junction, Cell Cycle,
and Actin Cytoskeleton Pathways (Table 2). Investigation of
Ad-repressed pathways revealed fewer significant findings, no
doubt due to the smaller number of genes repressed, but did
implicate particular repression of the G2/M checkpoint pathway
(p=9.2×10−5).Independent confirmation of microarray data and investigation
of ‘genomic effect’
To confirm the gene expression changes noted by the
microarray results, RNA was extracted and quantified after
reverse-transcription by quantitative real-time (qrt)-PCR. To
control for RNA loading, several “housekeeping” genes
(GAPDH, beta-actin, HMBS, and GUS) were also quantified,
with their geometric means used to normalize samples across all
target runs, a method validated by previous investigators
(Vandesompele et al., 2002; Schmittgen and Zakrajsek, 2000).
Additionally, to determine the theoretical impact that residual
Ad genome derived expression from the [E1−,E3−] Ad vector
might have on the results, MEF infections were repeated as
before, but infected with a UV-inactivated Ad vector. Finally, to
ascertain what impact protein expression (and/or cytokine
elaboration) might have on the results (i.e., between the time of
Ad infection and RNA isolation), MEFs were pretreated with
cyclohexamide (CHX) prior to Ad vector infection (Table 3).
Using these methods, we found a high degree of concordance
between array identified upregulated and downregulated gene
targets and qrt-PCR investigated targets, in both AdLacZ and in
UV-inactivated Ad-LacZ infected MEFs. Ad-mediated tran-
scriptome dysregulation was only partially affected by protein
synthesis suppression in the infected cells as the most potently
Ad affected genes were weakly affected, if at all, by
cyclohexamide-mediated protein inhibition (see Table 3). For
instance, some genes involved in cellular interferon or cytokine
responses, such as IRF-7 and CCL7, were affected by protein
synthesis inhibition, while more potently Ad-affected genes
(like the IFIT family members and Usp18) were completely
unaffected by protein synthesis inhibition. This finding also
supports the notion that high level reporter transgene expression
(bacterial β-galactosidase) is not responsible for transcriptional
differences observed in Ad-infected cells. Intriguingly, for a
wide-range of genes comprising many different functional
categorizations and pathways, infection by UV-inactivated virus
caused higher levels of upregulation than that occurring after
MEF infection with a viable [E1−,E3−] Ad. This strengthens
the notion that the Ad capsid initiates rapid and extreme host
transciptome responses (in particular with ‘Defense Response’
genes), and suggests that subsequent Ad genome derived
transcription products attempt to repress or capitalize upon this
capsid-initiated response (see Table 3). Additionally, while
many gene expression differences were proportional when
comparing qrt-PCR results to signal intensity values generated
from the microarray output, many interferon-related gene
inductions identified by array analysis were demonstrated to
have much higher fold inductions based upon real-time PCR
results. This was not entirely unexpected, as our stringent array
normalizations and standardizations could likely have had a
‘reduction effect’ on these known, virally sensitive immune
response genes.
A few of the array identified downregulated targets did not
meet our measure of statistical significance using (qrt)-PCR,
and in some rare instances, the real-time PCR data countered the
array results for a given probe set (Table 3). This is not entirely
Fig. 3. Significantly Ad-dysregulated Gene Ontology Groups. Statistically significant Ad dysregulated genes (one-way ANOVA, p=0.05, BH FDR) were classified
according to Gene Ontology (GO) function. The significantly affected GO groups (as determined by EASE analysis as described in Methods) were then grouped in pie
charts according to the number of total genes they represent within the upregulated or downregulated total listing of genes. Specific listings of genes for these groups
are available in Supplementary Tables 1–4.
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that are explained by differential transcript splicing, a lack of
microarray detection sensitivity, and/or other reasons (Woo et
al., 2004; Yauk et al., 2004; Shi et al., 2005; Tan et al., 2003).
Cytokine analysis
To further confirm differential expression of several genes
identified as Ad responsive, cytokine secretion by Ad-infected
MEFs was measured, the notion being that expressional
upregulation may translate into increased protein expression/
secretion. Confirming array-probe results, the protein levels for
IL-1α, IL-1β, mG-CSF, and mGM-CSF showed no change
(data not shown), while IL-6, CXCL1 (KC), MIP-1α, and
RANTES showed high levels of upregulation at the protein
level (Fig. 4). Induction of these cytokines mirrors those noted
after several Toll-Like Receptor (TLR) ligand stimulations of
primary fibroblasts suggesting that Ad infection activates the
host TLR system (Kurt-Jones et al., 2004).
Ad-induced transcription factors
We next sought to identify the transcription factors that may
be responsible for Ad-induced or suppressed gene families/
networks identified by the array derived data sets. Using
promoter sequence information derived from significantly Ad-
induced and non-induced genes, obtained from PromoSer
(Halees et al., 2003), and using a previously described
bioinformatics-based approach that employed the Relative
Over-Abundance of cis-elements (ROVER) program (Haverty
et al., 2004a,b), we identified transcription factor binding sites
over-represented in the promoters of Ad upregulated genes (andvirtually absent in the promoters of non-induced genes).
ROVER uses a binomial distribution calculation to identify
statistically significant over-representation of transcription
factor sites. The resulting probability of factor overabundance
(p value) can be interpreted as the likelihood that the specific
transcription factor regulates genes in the set (Table 4). Aside
from the obvious differential complexities rendered in ascer-
taining a cellular network, our analysis produced a partial
network of Ad-induced transcription factors and identified more
than 30 different transcription factors potentially involved in the
induction of the Ad innate immune response.
A resultant gene network of transcription factor-gene
regulation was produced in a graphical form using CARRIE
(available upon request) based upon these results.
The transcription factor with the highest overexpression
score (most statistically over-represented among the promoters
of Ad-induced genes) was the transcription factor Activator
Protein 1, AP1. Other highly over-represented transcription
factors included NF-kB family members, Interferon Regulatory
Factor (IRF) family members, T-Cell Factor (TCF) family
members, STAT1, and several nuclear hormone receptor
superfamily members (FXR-IR, FXR, PPAR/RXR). Several
of these transcription factors have been previously identified to
be important in host responses to other viruses, with NF-kB
having been previously identified as being induced by Ad
infection (Melotti et al., 2001). During the course of manuscript
submission, ATF3, ATF4, and KLF4, all predicted to be
induced by Ad infection, were confirmed independently
(Granberg et al., 2006). Additionally, our analysis identified
several additional and novel, Ad-induced transcription factors,
including Activator Protein 1 (AP1) BTB and CNC homolog 1
(BACH1), Pax-8, and Octamer Factor 1 (Oct1). None of these
Table 2
Significantly upregulated pathways after Ad infection in MEFs
Unregulated pathways Number of
Ad upregulated
pathway genes a
Locuslink IDs Gene names Enrichment b
Focal adhesion 14 11651; 12831; 12832; 12834; 14205;
15162; 18596; 19353; 20130; 20750;
21923; 22341; 22793; 60595
Akt1; Col5a1; Col5a2; Col6a2;
Figf; Hck; Pdgfrb; Rac1; Rras;
Spp1; Tnc; Vegfc; Zyx; Actn4
O=14; E=2.56;
R=5.4; p=3.77×10−7
MAPK signaling pathway 13 110651; 11651; 11909; 12475; 13163;
14182; 16478; 17187; 17873; 18596;
19353; 20130; 218397
Rps6ka3; Akt1; Atf2; Cd14;
Daxx; Fgfr1; Jund1; Max; Gadd45b;
Pdgfrb; Rac1; Rras; Rasa1
O=13; E=2.83;
R=4.6; p=6.5×10−6
Cell cycle 12 12428; 12442; 12447; 12534; 12580;
12914; 17215; 17219; 17220; 17873;
18538; 268697
Ccna2; Ccnb2; Ccne1; Cdc2a;
Cdkn2c; Crebbp; Mcm3; Mcm6;
Mcm7; Gadd45b; Pcna; Ccnb1
O=12; E=1.21;
R=9.8; p=3.58×10−9
Regulation of actin
cytoskeleton
9 117150; 12475; 14182; 18596; 19353;
19684; 20130; 29875; 60595
Cd14; Rras; Iqgap1; Rac1; Actn4;
Fgfr1; Pip5k2c; Pdgfrb; Rdx
O=9; E=2.48;
R=3.63; p=9.41×10−4
ECM-receptor interaction 8 11603; 12831; 12832; 12834; 16423;
20750; 21923; 319448
Cd47; D14Ertd453e; Agrn; Col5a1;
Col5a2; Col6a2; Spp1; Tnc
O=8; E=1.04;
R=7.70; p=9.93×10−6
Tight junction 8 11651; 16897; 18753; 18754; 19054;
20130; 20740; 60595
Rras; Actn4; Llglh; Prkcd; Prkce;
Ppp2r3a; Spna2; Akt1
O=8; E=1.43;
R=5.61; p=9.88×10−5
Adherens junction 8 12914; 14182; 19353; 20583; 21415;
29875; 380928; 60595
Crebbp; Iqgap1; Lmo7; Rac1; Actn4;
Fgfr1; Snai2; Tcf3
O=8; E=0.88;
R=9.13; p=2.74×10−6
Oxidative phosphorylation 7 11947; 11951; 170658; 17993; 27060;
67530; 67895
Atp5b; Atp5g1; Ndufs4; Ndufs5;
Tcirg1; Pyp; Uqcrb
O=7; E=1.38;
R=5.09; p=4.86×10−4
Calcium signaling pathway 6 12442; 12534; 12914; 17096; 18596;
268697
CCnb1; Ccnb2; Cdc2a; Gnas; Lyn;
Pdgfrb; Plc3b; Slc2514; Slc25a5
O=6; E=2.21; R=2.71;
p=0.02
Wnt signaling pathway 5 12914; 19353; 20319; 20437; 21415 Ccnd3; Fzd2; Plcb3; Ppp2ca;
Ppp2cb; Rac1; Rac2; Sfrp2; Siah1a;
O=9; E=1.74; R=2.87;
p=0.03
Jak-STAT signaling pathway 5 11651; 12914; 16164; 16391; 16451 Crebbp; Jak1; Isgf3g; Il13ra1; Akt1 O=5; E=1.81; R=2.76;
p=0.04
TGF-beta signaling pathway 5 12914; 13179; 15901; 15902; 15904 Crebbp; Dcn; Idb1; Idb2; Idb4 O=5; E=1.00;
R=5.00; p=3.35×10−3
Glycolysis/Gluconeogenesis 4 11529; 11668; 15275; 66204 Acyp1; Adh7; Aldh1a1; Hk1 O=4; E=0.63;
R=6.39; p=3.54×10−3
Cytokine–cytokine receptor
interaction
4 16164; 18596; 20306; 22341 Ccl7; Il13ra1; Pdgfrb; Vegfc O=5; E=2.93; R=1.71;
p=0.34
Toll-like receptor signaling
pathway
4 11651; 12475; 17874; 19353 Akt1; Cd14; MyD88; Nfkbia;
Pik3ca; Rac1; Rac2
O=4; E=1.18; R=5.93;
p=0.03
Phosphoinositides and their
downstream targets
4 11651; 17096; 18754; 19353 Rac1; Lyn; Prkce; Akt1 O=4; E=0.21;
R=18.81; p=1.17×10−4
p38 MAPK signaling pathway 4 11909; 13163; 17187; 19353 Daxx; Max; Rac1; Atf2 O=4; E=0.38;
R=10.66; p=7.98×10−4
mTOR signaling pathway 2 11651; 13681 Eif4a1; Akt1 O=2; E=0.25;
R=7.99; p=2.99×10−2
IL-7 signal transduction 3 12914; 16451; 64685 Crebbp; Jak1; Nmi O=3; E=0.16;
R=18.44; p=9.33×10−4
p53 signaling pathway 3 12447; 18538; 21859 Ccne1; Pcna; Timp3 O=3; E=0.20;
R=14.99; p=1.56×10−3
Influence of Ras and Rho
proteins on G1 to S transition
3 11651; 12447; 19353 Rac1; Ccne1; Akt1 O=3; E=0.30;
R=9.996; p=4.40×10−3
The information-processing
pathway at the IFN-beta
enhancer
3 11909; 12914; 16362 Crebbp; Atf2; Irf1 O=3; E=0.09;
R=34.25; p=2.11×10−4
Transcription factor CREB and
its extracellular signals
2 11651; 19353 Rac1; Akt1 O=2; E=0.21; R=9.40;
p=0.02
Pathways determined by hypergeometric tests using GOTM on significantly upregulated genes as described in Methods.
a Significantly upregulated genes after Ad infection that are found in the indicated pathways.
b Representation of Pathway enrichment in Ad upregulated genes. O indicates the number of genes observed in the list. E indicates the Expected number of genes
in the list. R indicates the relative enrichment of gene in the pathway, while p indicates the significance of this value as determined by a hypergeometric test.
362 Z.C. Hartman et al. / Virology 358 (2007) 357–372transcription factors have been previously implicated as
playing a role in Ad infection, although Oct1 binding elements
are present in the Ad genome.
IRF-7 was identified in this analysis, and was also found to
be highly induced in our array data sets, a result subsequentlyconfirmed by qrt-PCR (Table 3). IRF-7 expression (as part of a
interferon response) has recently been shown to be dependent
upon interactions with the Toll-Like Receptor Pathway (TLR),
specially the TLR-adaptor, MyD88 (Honda et al., 2004;
Grandvaux et al., 2002).
Table 3
Comparison of transcript fold changes after Ad infection by microarray and quantitative rt-PCR
Gene name Microarray fold change a qrt-PCR fold change (normal Ad) b qrt-PCR (UV-treated Ad) c qrt-PCR (normal Ad CHX-treated cells) d
Agl 0.21 (0.01 to 1.63) 0.61 (0.45 to 0.82) 0.55 (0.49 to 0.62) 0.99 (0.48 to 2.02)
CCL7 6.55 (1.54 to 17.67) 14.58 (8.06 to 26.37) 39.94 (24.47 to 65.19) 2.58 (1.14 to 4.72)
Daxx 2.50 (1.97 to 3.26) 11.90 (6.22 to 22.76) 9.26 (5.34 to 16.05) 2.64 (1.56 to 4.48)
Ddx5 2.71 (1.77 to 4.47) 2.06 (1.76 to 2.34) 1.60 (1.20 to 2.14) 2.38 (1.44 to 3.93)
Eef1a1 2.11 (1.20 to 3.33) 1.70 (0.71 to 4.09) 2.17 (1.80 to 2.60) 0.79 (0.44 to 1.43)
Fhl1 0.66 (0.55 to 0.73) 0.80 (0.70 to 0.92) 0.48 (0.32 to 0.72) 1.36 (0.83 to 2.23)
Gbp2 7.14 (2.89 to 13.82) 96.22 (75.90 to 121.98) 192.51 (163.15 to 227.15) 195.20 (100.65 to 378.54)
Gbp4 179.70 (116.6 to 277.65) 170.70 (75.95 to 383.70) 127.58 (81.68 to 199.27) 223.17 (119.31 to 417.42)
Gna12 0.03 (0.01 to 0.25) 0.47 (0.28 to 0.76) 0.71 (0.44 to 1.14) 0.24 (0.06 to 0.91)
H3f3a 2.30 (1.38 to 3.29) 1.97 (1.74 to 2.22) 1.70 (1.37 to 2.12) 3.81 (2.49 to 5.85)
Hspa8 2.55 (1.55 to 5.15) 2.10 (1.93 to 2.29) 1.76 (1.25 to 2.49) 1.22 (0.75 to 1.97)
IFIT1 59.18 (25.42 to 155.01) 234.64 (157.03 to 350.61) 378.26 (297.01 to 481.72) 421.65 (198.39 to 896.34)
IFIT2 11.86 (5.13 to 25.72) 185.26 (97.33 to 352.65) 314.62 (238.04 to 415.84) 137.51 (71.78 to 263.44)
IFIT3 23.47 (12.34 to 30.19) 497.01 (379.63 to 650.68) 472.20 (377.25 to 591.06) 305.76 (123.67 to 755.94)
IP-10 17.48 (8.20 to 69.24) 8803.15 (6970.95 to 11116.89) 13154.47 (11576.02 to 14948.16) 1118.33 (604.13 to 2070.12)
IRF-7 14.37 (8.49 to 22.64) 52.66 (32.54 to 85.24) 160.18 (106.35 to 241.27) 19.23 (13.10 to 28.23)
LGals3bp 18.24 (10.01 to 31.95) 11.44 (6.84 to 19.13) 19.51 (14.43 to 26.38) 5.56 (3.70 to 8.37)
MyD88 2.39 (1.55 to 4.19) 3.02 (1.63 to 5.60) 4.80 (4.07 to 5.65) 1.42 (0.81 to 2.46)
NMI 9.99 (7.38 to 14.08) 10.21 (7.08 to 14.72) 12.49 (10.89 to 14.31) 8.57 (4.20 to 17.48)
Pgam1 0.23 (0.12 to 0.38) 0.69 (0.14 to 3.31) 0.87 (0.54 to 1.38) 1.39 (0.86 to 2.26)
Ptdss2 0.36 (0.24 to 0.78) 0.57 (0.45 to 0.73) 0.54 (0.48 to 0.60) 2.47 (1.86 to 3.29)
Samhd1 2.09 (1.64 to 3.20) 5.31 (4.88 to 5.77) 9.18 (8.12 to 10.39) 11.98 (5.23 to 27.43)
Usp18 27.18 (16.65 to 36.29) 660.37 (533.38 to 817.15) 601.85 (549.30 to 659.43) 784.41 (447.00 to 1376.49)
Quantitative rt-PCR was used to validate Ad-mediated changes in genes expression observed using microarrays. Values generated from qrt-PCR were in high
concordance with those observed using microarrays.
a Average microarray fold changes after Ad infection with respect to the average from mock-infected cells. Values in parentheses represent the highest and lowest
observed fold changes.
b Average qrt-PCR fold changes after Ad infection with respect to the average from mock-infected cells. Values in parentheses represent the fold difference value
plus or minus the standard deviation or the 95% confidence interval.
c Average qrt-PCR fold changes after UV-treated Ad infection with respect to the average from mock-infected cells. Values in parentheses represent the fold
difference value plus or minus the standard deviation or the 95% confidence interval.
d Average qrt-PCR fold changes after CHX-treated cells were subjected to Ad infection with respect to the average from CHX-treated mock-infected cells. Values
in parentheses represent the fold difference value plus or minus one standard deviation or the 95% confidence interval.
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cellular nuclei derived from mock-infected, Ad-infected, or
UV-Ad-infected human A549 cells were assayed through an
Electrophoretic Mobility Shift Assay (EMSA) (see Fig. 5). We
focused our investigation on two transcription factors predicted
to be induced by our analysis, AP1 (the transcription factor
with the highest over-representation score) and Oct1 (a
transcription factor with a more modest score). EMSA
confirmed that AP1 was significantly induced after both Ad
and UV-inactivated Ad infection, but investigations of Oct1
patterns revealed intriguing differences (Fig. 5). Oct1 specific
probes revealed two distinct banding patterns in A549 cells,
potentially indicative of multiple Oct1 motif-binding transcrip-
tion factors. Interestingly, there was significant induction in Ad
and UV-irradiated Ad infected A549 cells of certain Oct1-
specific bands, but there was also simultaneous repression of
other Oct1-specific bands in both Ad and UV-inactivated Ad-
infected cells. In both cases (induction and repression), a more
exaggerated response is seen in the UV-inactivated Ad-infected
cells. These latter results may in part be explained by residual
Ad genome products repressing the induction of Oct1-binding
transcription factors at these time points (Pruijn et al., 1988;
Hatfield and Hearing, 1993, 1991; Bosher et al., 1990;
Mesplede et al., 2005).Investigation of the TLR pathway in human A549 cells
Experimental evidence of Ad induction of different
immune gene groups, TLR pathway genes, and IRF, AP,
and Oct transcription factors families in MEFs and/or A549
cells strongly implicated the involvement of the TLR pathway
in the induction of intracellular Ad immunity (Akira et al.,
2006). Our array analysis also implicated the involvement of
the mitochondria in Ad immune signaling, and a recent report
had also implicated TRIF signaling upstream of the Mito-
chondrial Antiviral Signaling Gene (MAVS, IPS-1, or VISA)
as a potential interacting factor in the TLR system (Xu et al.,
2005). Since human A549 cells have also been shown to
express all TLRs (Hou et al., 2006), are highly responsive to
Ad infection, and are more amenable to experimental
manipulation (transfection and selection), we decided to
focus our next efforts on probing the role of several key
signaling TLR adaptors using these cells. Specifically, we
employed NF-kB and Interferon-beta-dependent luciferase
reporter gene constructs to monitor Ad-mediated immune
induction in these cells.
We also constructed stable A549 cells harboring shRNA
cassettes targeting MyD88, TRIF, or MAVS expression.
Quantitative rt-PCR and Northern blots confirmed knock-
Fig. 4. Cytokine production in Ad-infected MEFs. MEFs were cultured as previously described and infected with a LacZ Ad (MOI=300) or Mock-infected.
Supernatants were collected at various time points and cytokine production determined through use of a Luminex ELISA assay. Data are averages (n=3) and bars
represent standard deviations, *p≤0.05, **p≤0.01, compared with mock-infected cells.
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cells, ∼75% in TRIF knock-down cells, and ∼75% in MAVS
knock-down cells compared to GAPDH controls (data not
shown). When NF-kB and Interferon-beta-dependent luciferase
expression experiments were performed on these lines, both
NF-kB and Interferon-beta-dependent induction of luciferase
were significantly diminished in the MyD88, TRIF, and MAVS
knock-down cell lines (Fig. 6A). We also infected these stable
knock-down cell lines with Ad, and assessed the secretion of IL-
6 in supernatants at 24 hpi. As with MEFs, mock-infected A549
cells had undetectable levels of IL-6, but upon Ad infection
significant levels of IL-6 were detected at 24 hpi (Fig. 6B).
More importantly, IL-6 secretion was also significantly reduced
in MyD88, TRIF, and MAVS knock-down cell lines. Thus, in
A549 cells, it seems likely that the TLR system plays a role in
the induction of several aspects of the Ad innate immune
response, as per array-based predictions.
Discussion
The present study evaluated the impact that Ad transduction
has on the transcriptome of a cell, by using micoarray-based
transcriptome analysis. We have experimentally influenced the
microarray analysis by using a homogenous population of
primary cells (MEFs) that are known to retain a full innate
response sensing repertoire. The findings in the murine system
were further validated in human cells (A549), which were
also specifically interrogated to ascertain involvement of theTLR system in Ad-induced transcriptome and innate immune
responses.
While Ad is known to have a multi-staged and complex entry
mechanism involving integrin signaling, endosomal disruption,
and nuclear invasion, the finding of such large gene and
cytokine inductions in “non-immune” quiescent cells sheds new
light on putative reasons for Ad vector associated ‘toxicities.’
Our results demonstrate that Ad activates a widespread gene
expression program even in cells (MEFs) that do not fulfill a
specialized immunological role, but are apparently no less
adequately equipped to innately detect pathogen infections.
While past studies have identified an Ad ‘response’ in many
different kinds of cells, this study is the first to identify and
characterize this global immune response in a primary non-
immune cell type (Liu et al., 2003; Liu and Muruve, 2003;
Tibbles et al., 2002; Zaiss et al., 2002; Hirschowitz et al., 2000;
Korst et al., 2002; Lyakh et al., 2002).
Our findings confirm and expand earlier findings suggestive
of transcriptome dysregulation in immortalized cell lines after
infection with E1 deleted Ad vectors or empty Ad shells
(Stilwell and Samulski, 2004; Stilwell et al., 2003; Volk et al.,
2005). These previous studies described a relatively moderate
transcriptome dysregulation, approaching ∼4.2% of all ascer-
tainable genes in IMR-90 cells and ∼14% in M21 cells,
substantially less than the ∼22% of Ad dysregulated genes we
noted after Ad infection of MEFs. These differences could be
due to the ubiquitous expression of all TLRs in MEFs (versus
the unknown levels of TLR expression in these particular lines),
Table 4
Over-represented transcription factor binding sites in the promoters of Ad-induced significantly upregulated genes
Murine transcription factor binding site p-value Human transcription factor binding site p-value
AP-1 3.86×10−05 AP-1 4.81×10−05
FXR inverted repeat 1 5.99×10−05 AREB6 (Atp1a1 regulatory element binding factor 6) 4.98×10−05
Gut-enriched Krueppel-like factor (KLF4) 1.17×10−04 FXR inverted repeat 1 4.98×10−05
FXR 1.40×10−04 TCF11/MafG heterodimers 1.35×10−04
c-Rel 1.16×10−04 FXR 1.40×10−04
BTB and CNC homolog 1 3.03×10−03 HNF-6 7.20×10−04
Hox-1.3 4.03×10−03 c-Rel 1.03×10−03
Estrogen-related receptor alpha 4.03×10−03 SOX (SRY-related HMG box) 1.53×10−03
Sox-5 6.33×10−03 BTB and CNC homolog 1 2.52×10−03
Octamer factor 1 6.33×10−03 Estrogen-related receptor alpha 4.02×10−03
NF-kB (p65) 7.32×10−03 RAR-related orphan receptor alpha1 5.39×10−03
Signal transducer and activator of transcription 1 7.64×10−03 Octamer factor 1 6.58×10−03
CP2 7.64×10−03 NF-kB (p65) 7.72×10−03
COMP1 1.19×10−02 Signal transducer and activator of transcription 1 8.38×10−03
PPAR/RXR heterodimers 1.19×10−02 Transcriptional repressor CDP 8.38×10−03
Pax-8 binding sites 1.30×10−02 Pax-8 binding sites 1.62×10−02
Nuclear factor Y (Y-box binding factor) 1.63×10−02 Nuclear factor Y (Y-box binding factor) 2.04×10−02
SRF 1.91×10−02 SRF 2.34×10−02
NF-E2 p45 2.37×10−02 Interferon regulatory factor 7 2.34×10−02
Hepatic nuclear factor 1 2.89×10−02 AP-3 2.56×10−02
c-ETS-1 binding site 3.22×10−02 NF-E2 p45 2.67×10−02
Pit-1 4.10×10−02 ATF binding site 2.79×10−02
NKX6-1 4.10×10−02 Hepatic nuclear factor 1 3.13×10−02
NF-1 4.42×10−02 c-ETS-1 binding site 3.52×10−02
NK2 class homeobox factor 2 4.42×10−02 Pit-1 4.51×10−02
LIM homeobox transcription factor 3 4.97×10−02 NKX6-1 4.51×10−02
PPAR-gamma (peroxisome proliferator-activated receptor gamma) 4.51×10−02
Myocyte enhancer factor 4.60×10−02
NF-1 4.60×10−02
NK2 class homeobox factor 2 4.60×10−02
Transcription factor binding motifs that are significantly over-represented in the promoters of Ad-induced genes compared the promoters of Ad non-induced genes. Ad
significantly induced genes (one-way ANOVA with FDR, p<0.05 and fold induction <2.5) and Ad non-induced genes (p>0.75 and fold dysregulation >0.75 and
<1.25); promoters for genes were obtained from PROMOSER (−2000 bp to +500 bp) relative to the transcription initiation site. Binding preferences were taken from
given Position Specific Scoring Matrix information from the TRANSFAC 7.2 and JASPAR transcription factor databases and used to calculate the likelihood of over-
representation of binding motifs for particular factors in the positive set (Ad-induced genes) in comparison to the negative set (non-Ad-induced genes). The resulting p
value is a probability of over-abundance and can be interpreted as the likelihood of the transcription factor regulating Ad-induced genes.
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vector infection, or differences in the number of replicates
examined between the studies. Our approach using a larger
number of replicates could have helped yield the statistical
strength to successfully identify a larger number of Ad-affected
genes. Specifically, this investigation revealed that many Ad-
induced gene groups have predominantly defensive functions,
including ‘Defense Response,’ ‘Antigen Presentation’, and
‘Heat Shock Activity’ clusters of genes. The strong induction of
the specific ‘MAP Kinase,’ ‘Jak-STAT,’ and ‘Toll-Like
Receptor’ pathways is also indicative of a strong intracellular
innate reaction to Ad infection, and taken together, reveals that
the primary Ad response of these ‘non-specialized’ cells is a
defensive reaction to pathogen invasion.
The activation of the ‘Focal Adhesion’ and ‘Tight Junction’
pathways suggest a potent, Ad-induced dysregulation of
epithelial barrier systems, potentially mediated through activa-
tion of Akt through ανβ5 integrin signaling as demonstrated in
human REC cells (Liu et al., 2005). Intriguingly, recent studies
suggest that Focal Adhesion Kinase pathways are interlinked
with Toll-Like Receptor pathways (Cetin et al., 2004; Zeisel et
al., 2005). Also, focal adhesion activity has recently beendemonstrated as essential for viral capsid entry and transloca-
tion to the nuclear pore for Herpes Simplex Virus (HSV)
(Cheshenko et al., 2005). It is thus possible that Ad infection
induces Focal Adhesion activation for proper nuclear targeting,
with any resultant barrier dysfunction functioning to facilitate
the spread of progeny virions from cell to cell.
Likewise, the host cell's cytoskeleton is a major target for
pathogens, for purposes including attachment, entry into cells,
and movement within and between cells (Gruenheid and Finlay,
2003). Significant Ad induction of ‘actin cytoskeletal’ regula-
tory genes and ‘GTPase activity’ genes (including Cdc42 and
Rac) suggests that a substantial portion of transcriptome
dysregulation by Ad promotes expression of gene programs
enabling efficient cytoskeletal rearrangement and Ad trafficking
to the nucleus (Li et al., 1998).
Ad infection triggers significant induction of ‘Cellular
Proliferation,’ ‘Cell Cycle,’ and ‘DNA replication’ gene groups
and repression of ‘Biosynthesis,’ ‘Metabolism,’ and ‘energy
derivation from oxidation’ gene groups. Proliferation and
metabolic suppression likely reflect the two opposing forces
at work in the cell after Ad infection. Pathways and genes
induced by the virus to promote virus propagation (upregulated
Fig. 5. Ad-infected A549 EMSAs. Representative EMSAs from Ad-infected A549 cells are shown in panel A. EMSA gels were subjected to a densitometric assay
using ImageQuantTL (Amersham) (B). Average density was calculated from free probe and non-specific competitor lanes across all experiments and calculated as a
fold increase vs. respective mock-infected controls set to 1.0. Bars represent standard deviations of averaged free probe and non-specific competitor samples, and
*p≤0.05, **p≤0.01, compared with mock-infected cells.
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may be countered by suppression of these latter genes by the
host cell as a defensive response to limit pathogen growth.
Ad-induced genes were generally upregulated to higher
levels after UV-inactivated Ad infection, relative to increases
induced by E1 deleted Ad vectors. These findings suggest that
ablation of residual Ad genome function could be eliminating
native functions of early Ad proteins to diminish the innate
immune response and restrain cellular defensive mechanisms,
as has been shown in the case of Ad E1 and VA RNA genes.
These results are in slight contrast to results obtained by
Stillwell et al. who found only modest capsid-dependant gene
dysregulation after infection with ‘empty’ Ad capsids, but can
be explained by the different nature of the particles tested in
question (intact capsid versus a distended one) and the presence
of damaged DNA in the UV-inactivated Ads, versus the lack of
DNA in ‘empty capsids’ utilized by Stilwell et al. (2003). The
presence of DNA outside the nucleus has recently been shownto activate a cellular immune response, likely giving ‘loaded’
capsids a more potent immune signal (Spies et al., 2003; Okabe
et al., 2005; Stetson and Medzhitov, 2006; Wagner and Bauer,
2006). Additionally, this slight induction might be due to a
labilizing effect of the UV light on the Ad capsid, thereby
causing it to more easily release its DNA in the cell, as was
described for UV-treatment of Reovirus particles (Henderson
and Joklik, 1978). Nuclear transduction of UV ‘damaged DNA’
could also be playing a role in the greater immunostimulatory
signaling mechanisms following UV-Ad infection.
Our results in Ad-infected, CHX-treated MEFs also
indicated that most of the significant Ad-mediated gene
expression changes were not attributable to a secondary
cellular response to host cell derived inflammatory mediators.
These findings mirror earlier findings of Ad-mediated
induction of several interferon stimulated genes (G1p2,
IFIT1, and IFIT2), independent of protein synthesis, in HeLa
cells (Reich et al., 1988). Thus, Ad-mediated transcriptome
Fig. 6. Diminished Ad induction of immune reporters and IL-6 secretion through
TLR adaptor gene repression in A549 cells. (A) Stable knock-down A549 cells
for MyD88, TRIF, MAVS, or control shRNA constructs were transfected with
NF-kB or IFN-β Luciferase reporters and then infected with Ad or mock-
infected. At 16 hpi, luciferase induction between equivalently transfected cells
was assessed. (B) Stable-knock down cells lines for MyD88, TRIF, or MAVS
were infected with Ad or mock-infected. At 24 hpi, supernatants were collected
and IL-6 concentrations assessed by ELISA. Data from all experiments (A–C)
are averages (n=3) and bars represent standard deviations, *p≤0.05, **p≤0.01,
compared with Ad-infected control cells. LacZ staining indicated that all cell
lines were equally transduced by the LacZ expressing Ad (data not shown).
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precipitated by direct signaling immediately upon cellular
infection by an Ad capsid.
An “Ad gene induction network” was constructed using a
fusion of microarray, genomic, and transcription factor
information. A strong induction of interferon, NF-kB, KLF4,
AP-1, and Oct-1 (in UV-irradiated cells)-dependent genes was
noted by this analysis, a result congruent with previous studies
that showed NF-kB and KLF4 induction after Ad infection
(Granberg et al., 2006; Melotti et al., 2001; Bowen et al.,
2002; Loser et al., 1998). Of note, while our array analysis
showed no induction of KLF4 transcripts at 16 hpi (data not
shown), we were able to detect the earlier induction of this
transcription factor through an analysis of the promoter regions
of Ad-induced genes at the later time point (Granberg et al.,
2006).
Induction/upregulation of AP-1, NF-kB, IRF-7, and TLR
associated genes (primary constituents of the TLR innate
sensing network), implicated the TLR sensing mechanism as
active after Ad infection. Investigation of MyD88, TRIF, and
MAVS through shRNA-mediated knock-down revealed them to
each play a role in the Ad induction of Interferon-beta and NF-
kB-dependent genes, as well in the secretion of IL-6.
Previously, studies in TLR4 mutant mice, (the TLR known torespond to LPS via interactions with MyD88 and TRIF), have
also shown a diminished cytokine response in an Ad-lung
challenge model (Thorne et al., 1999). However, it is important
to note that the TLR system may not be the only determinant of
the Ad innate immune response, as evidenced by the continued
induction of immune response promoters in knock-down lines
in comparison to mock-infected cells.
Our finding of significant repression of mitochondrial-
related genes after Ad infection, combined with our confir-
mation that MAVS is important in Ad induction of NF-kB and
IFN genes, suggests that mitochondria play several important
roles in Ad innate immune signaling. The recent discovery of
MAVS has prompted this type of investigation with other
pathogens, suggesting a potential common pathogen mito-
chondrial-signaling mechanism (Seth et al., 2005; McWhirter
et al., 2005).
While the present work is likely to elicit many new
hypotheses, it is quite evident that Ad infection induces a
rather potent immune response that functions to limit viral
replication through a common activation of immune, growth
arrest, and RNA regulatory pathways, a response partially
dependent upon the TLR system. At the same time, much of
the host transcriptome response is likely precipitated by the Ad
capsid itself, with the virus taking advantage of nuclear
trafficking, cell cycling, DNA replication functions, and
potential activation and disruption of epithelial barrier gene
functions. It is important to note that all viral vectors (deleted
of some or all wild-type viral genes) likely activate these
responses to varying degrees after transducing cells. Thus,
therapies that seek to use alternate viral vectors for gene
transfer or immunization purposes should be aware of the
severity and complexity of this response at a cellular level, as
well as its consequences for its relevant host organism. While
the duration of this response was not investigated in our study,
the severity noted at our singular time point is likely to heavily
impact an organism when a high cellular volume is effectively
transduced. Furthermore, as the fundamentals of these
responses are better understood, therapies will be able to
more effectively manipulate viral vectors in order to ensure
safety, maximize therapeutic efficacy, and capitalize on their
unique potentials.
Methods
Cells and viruses
Primary wild-type mouse embryo fibroblasts were prepared
from 13.5 days post-conception (dpc) C57Bl/6 embryos as
described by (Robertson, 1987). Cells were passaged in DMEM
and 15% heat-inactivated bovine serum (HIFBS). Fibroblasts
were frozen under liquid nitrogen at passage 2 following initial
culturing. All subsequent experiments were initiated with these
passage 2 fibroblasts. After thawing, the cells were passaged
once in DMEM and 15% HIFBS, then rendered quiescent in
DMEM and 0.2% HIFBS for 48 h. The [E1−,E3−] 1st
generation Ad vectors used in our study expressing the bacterial
β-galactosidase (LacZ) were generated as previously described
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subcloned into a shuttle plasmid and placed under the
transcriptional control of a CMV promoter, and used to
generate [E1−,E3−] vectors using a previously described,
bacterial recombination-based system (He et al., 1998).
Complementing 293 cell lines were used to produce high
titers of these vectors, cesium chloride double banding was
performed to purify the vectors, and vectors were titered by
anti-72 kDa staining and LacZ transducing unit titering as
previously detailed (Amalfitano and Chamberlain, 1997;
DeGregori et al., 1995; Nevins, 1980). A549 cells were
obtained from the American Tissue Culture Collection
(ATCC). Ad preparations were also tested for LPS contami-
nation using an E-Toxate Assay (Sigma) and were all found to
have less than 0.5 Endotoxin Units per mL. Fibroblasts were
either mock-infected, or infected at a multiplicity of infection
(MOI) of 300 LacZ transducing units per cell, for 16 h. This
infection protocol resulted in ∼90% LacZ positive cells upon
X-gal staining. Cells were then harvested, and total RNA was
prepared using the Trizol reagent per manufacturers' recom-
mendations (Invitrogen).
Transient transfection and luciferase experiments
For transient transfection experiments, MEFs were plated in
24 well dishes at a density of 2.5×105 cells per well and
transfected with 500 ng of the Luciferase reporter plasmid, 150
ng of the respective expression construct, and 150 ng of
pcDNA3.1/His/LacZ (Invitrogen) and pMaxEGFP (Amaxa) as
transfection and DNA content controls using Calcium Phos-
phate transfection (Invitrogen) according to the manufacturer's
protocol. NF-kB Luciferase (Stratagene) and Interferon-beta
Promoter constructs, generously provided by Dr. Barbara
Sherry (Stewart et al., 2005) and Dr. John Hiscott (Juang et
al., 1998), were used as reporter vectors. After transfection, cells
were infected with [E1−,E3−] Ad vectors, UV irradiated Ad
vectors (∼400 mW/cm2), or mock-infected. The UV treatment
used a dose shown to yield more than a 6-log10 inactivation of
Type C Ads (Gerba et al., 2002). X-Gal stained replica plates of
UV-inactivated Ads revealed no detectable transgene expres-
sion per 106 cells, confirming the efficacy of this UV dose.
Sixteen hours after infection, cells were lysed and Luciferase
activity assayed using a Berthold Luminometer and normalized
for β-galactosidase activity using a Beta-Gal Assay kit
(Stratagene).
Microarray preparation, hybridization, and preliminary
analysis
We used Affymetrix Mu11K A/B GeneChips for all
experiments using methods described previously, and as
described by the manufacturer (Black et al., 2003; Huang et
al., 2003). Prior to use, quality controls were performed on
extracted RNA using an Agilent Lab-on-a-Chip 2100
Bioanalyzer (Agilent Technologies, Palo Alto, USA) following
manufacturer recommended guidelines and practices. Briefly,
double-stranded cDNA was synthesized from total RNA (10 gstarting material) extracted from the treated fibroblasts. Biotin-
labeled cRNA was next generated by in vitro transcription of
the cDNA. The cRNA was fragmented, and combined with
probe array controls, bovine serum albumin, and herring sperm
DNA. The cocktail was then hybridized to the oligonucleotide
DNA probes on the array for a 16-h incubation at 45 °C. The
hybridized array underwent an automated washing and
staining protocol on an Affymetrix fluidics-station. The
DNA chips were scanned with the Affymetrix GeneChip
scanner and the fluorescent signals processed by the GeneChip
expression analysis algorithm (v.2; Affymetrix). Raw data sets
were annotated with descriptions (as per MIAME guidelines)
and deposited into the Gene Expression Omnibus (GEO)
database at NCBI as Series Accession GSE3172 (http://www.
ncbi.nlm.nih.gov/geo/).
QRT-PCR and ELISA
To assess validity of gene induction after Ad infection of
primary fibroblasts, extracted RNA was subjected to qrt-PCR.
Briefly, fibroblasts were starved into quiescence and infected
at an MOI of 300 (as titered on 293 cells and corresponding to
roughly 30,000 particles per cell in our preparations) with
replica plates infected either by a [E1−,E3−] LacZ expressing
Ad vector, or a UV inactivated virus (∼400 mW/cm2), a dose
shown to yield more than a 6-log10 inactivation of Type C Ads
(Gerba et al., 2002). X-Gal stained replica plates of UV-
inactivated Ads revealed no detectable transgene expression
per 106 cells, confirming the efficacy of this UV dose. To
further corroborate the efficacy of this UV inactivation dose,
qrt-PCR was performed on the E4orf6 gene locus at the
opposite end of the Ad genome (see Supplementary Fig. 1).
This assay revealed a greater than two log reduction in E4orf6
transcription in UV-Ad-infected fibroblasts in comparison to
viable Ad-infected fibroblasts, with UV-treated Ad transcrip-
tion values being not significantly different from background
mock-infected levels. These controls were performed to
ascertain capsid-dependant influences on differential gene
expression. For cyclohexamide-treated controls, 3 h prior to
infection, MEFs were treated with 100 μg/mL of cyclohex-
amide (CHX), a dose exceeding or equal to the amount used in
other studies utilizing this agent for protein synthesis
inhibition in MEFs (Tournier et al., 2000; Ding et al., 2006;
Tam et al., 1999). This dose was maintained throughout
infection, until cells were processed at 16 hpi. X-Gal staining
for LacZ activity at 16 hpi also indirectly confirmed a strong
suppression of protein synthesis at this dose in the CHX-
treated cells. Sixteen hours after infection, RNA was extracted
using Tri Reagent (Molecular Research Center, Inc.) and
reverse transcribed (after DNAse treatment) using iScript
(BioRad) as per the manufacturer's recommendations. Quan-
titative PCR was performed on an ABI 7900 and MyiQ (Bio-
Rad) systems using the Qiagen Quantitect SYBR Green PCR
kit. In genes where introns are present, primers used in this
experiment were targeted to span introns (exact sequences
available in the Supplementary Table 5). The expressions of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Beta
369Z.C. Hartman et al. / Virology 358 (2007) 357–372Actin, hydroxymethylbilane synthase (HMBS), and beta
glucuronidase (GUS) were used as loading controls.
RNAi experiments and creation of shRNA knock-down lines
All knock-down lines were produced using the Hannon and
Elledge Human shRNA Library available through the Duke
University RNAi Core Facility (Silva et al., 2005). Briefly, shuttle
plasmids containing the shRNAs (V2HS_152058,V2HS_152059,
V2HS_214373, V2HS_217254; V2HS_49551; V2HS_49553)
were obtained from the core and retroviruses made using
previously described protocols (Naviaux et al., 1996). These
retroviruses were used to infect human A549 cells, which were
subsequently selected using a 2 μg/mL concentration of
puromycin. Cell lines were obtained by culturing puromycin
resistant cells. These cell lines were then assayed by PCR for the
presence of the shRNA cassette and for their knock-down status
through qrt-PCR and Northern Blot. Knock-down lines were
tested in tandem along with A549 control cell lines (empty
vector and sirtuin type 2 knock-downs, generously provided by
P. Yao, Duke University) using the conditions and treatments
previously described.
Cytokine analysis
Secretion of cytokines by the infected fibroblasts was
quantified using a multi-plex Enzyme Linked Absorbance
Assay (ELISA). Briefly, supernatants were harvested from Ad-
infected and mock-infected cells at 0, 6, 16, and 24 h post-
infection. Samples were then quantified using a Luminex Array
reader and the Bio-Rad, BioPlex Cytokine 18 mouse plex kit
using the manufacturer's recommendations, at the Duke
University Human Vaccine Institute Immune Reconstitution
Core Facility.
Statistical analysis
Expression data from the 24 Affymetrix data sets were
imported into Genespring 6.2, where standard default normal-
izations were applied. Briefly, microarray values below 0.01
were all set to 0.01. As a first check to ascertain global RNA/
microarray signal quality, the base error model deviation from
1 in each individual sample was inspected and in all but one
case were less than 31 (Avg. Base/Proportional 44.25). In the
single array set where a higher base error value was obtained,
array quality was deemed unacceptable and was discarded
from analysis. To normalize measurements per set and
eliminate differences between microarray sets, each measure-
ment was divided by the 50.0th percentile of all measurements
within the sample group. To normalize expression on a per
gene basis, each gene was divided by the median of its
measurements in all samples. If the median of the raw values
was below 10, then each measurement for that gene was
divided by 10. After data were normalized, they were filtered
with respect to flag calls, and those genes with a majority of
samples (more than 4) showing absent calls were eliminated
from further analysis. As a result of these normalizations andfiltering schemas, only ∼5300 of the original 11,000 probe
sets were available for subsequent analysis. To stringently
identify a list of genes with statistically significant differences
in gene expression between mock or Ad-infected cells, one-
way parametric ANOVA tests were performed using Benja-
min–Hochberg False Discovery Rate multiple testing correc-
tion with a p value of .05 and by fold upregulation, imported
using Unigene IDs (to limit redundancy) and compared to a
global murine transcriptome to ascertain overexpressed
functional groups of genes. The list of differentially expressed
genes was further analyzed through use of Expression
Analysis Systematic Explorer (EASE v2.0) using standard
protocols previously described (Hosack et al., 2003). For
secondary analysis, these lists were further interpreted and
analyzed using Gene Ontology Tree Machine (GOTM) and
Ontology Express (Onto-Express) using standard methods
(Zhang et al., 2004; Khatri et al., 2005).
To identify putatively induced transcription factors, micro-
array data were further analyzed through use of Computational
Ascertainment of Regulatory Relationships (Inferred from
Expression) or CARRIE and Relative OVER-Abundance of
cis-elements or ROVER, using standard protocols and methods
previously described (Haverty et al., 2004a, 2004a). Promoters
for all genes analyzed on the microarray (normalized and
passing filters for flags) were obtained from PromoSer (http://
biowulf.bu.edu/zlab/Promoser/) (Halees et al., 2003). Regions
2000 nucleotides upstream and 500 nucleotides of the
transcription start site that had quality and support values of
at least 1 were used. Of the ∼5300 normalized and filtered
genes used in ANOVA and EASE analysis, we were able
recover promoter sequence from ∼2000 genes for use in
CARRIE analysis with the murine TRANSFAC 7.2 and
JASPAR transcription factor matrix databases (Matys et al.,
2003; Sandelin et al., 2004).
Statistics for ELISA data were performed using a two-tailed
homoscedastic Student's t-test to determine significant differ-
ences in differential expression of cytokines and/or chemokines
between control and experimental groups.
Nuclear extraction and EMSAs
A549 cells were infected and nuclei harvested at 16 h post-
infection using a modified method as described in Schreiber et
al. (1989). Briefly, cells were washed 16 h after infection three
times with ice cold PBS. Cells were then harvested into PBS,
centrifuged and re-suspended in hypotonic 10 mM KCl. A mild
detergent treatment (0.6% SDS) was then used to lyse the cells,
and cytoplasmic supernatant was removed by centrifugation.
Pelleted nuclei were resuspended, lysed, and re-centrifuged.
Supernatant from the nuclear extract was quantified for protein
concentration by Bradford Assay (Bio-Rad) and utilized in a
Gel Shift Assay System (Promega) to ascertain differential in
transcription factor induction. Oligonuceotides for the AP1 and
OCT1 are consensus standards and are included in the Gel Shift
Assay System (Promega). After exposure, films were scanned
and converted to tiff files that were subjected to densitometric
analysis using the ImageQuant TL v2005 system (Amersham)
370 Z.C. Hartman et al. / Virology 358 (2007) 357–372to provide a quantitative measure of transcription factor
induction difference.
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